Importance: Patients with sexually transmitted infection (STI) diagnosis should be tested for human immunodeficiency virus (HIV), regardless of previous HIV test results. Objective: Estimate HIV testing rates among recent service Veterans with an STI diagnosis and variation in testing rates by patient characteristics. Design, Setting, and Participants: The sample comprised 243,843
A lthough the Centers for Disease Control and Prevention (CDC) recommends universal human immunodeficiency virus (HIV) testing for individuals aged 13-64 years, 1 nearly 200,000 Americans are unaware of their HIV infection. More frequent HIV testing for high-risk individuals, such as those diagnosed with sexually transmitted infection (STI), may help reduce that number as STIs can facilitate HIV transmission through direct biological mechanisms. Over 20 million new STIs occur each year in the United States. [2] [3] [4] Between 2006 and 2011, rates increased by 10% among men and women aged 20-39 years, and among young black men the rate of syphilis increased by 134%. 5 However, HIV testing among patients diagnosed with an STI is suboptimal. 6 Since 2001, over 1.5 million US Armed Forces personnel have been deployed at least once in support of Operations Enduring Freedom, Iraqi Freedom, and New Dawn (OEF/OIF/OND), and over 1 million Veterans have returned from service. Data on HIV testing among Veterans are important. First, military populations have higher STIs rates compared with the civilian population, rates increase during times of armed conflict, [7] [8] [9] and STI risk behaviors may continue past the end of service. [10] [11] [12] Second, Veterans are younger and more likely to be racial and ethnic minorities, 13 groups disproportionately affected by both STIs and HIV. 2 Third, conditions which increase both STI and HIV risk, including substance abuse and posttraumatic stress disorder (PTSD), are prevalent among Veterans in Veterans Health Administration care (VHA). 14, 15 CDC recommends HIV testing for individuals who are diagnosed with or suspected to have an STI. 16 Therefore, we sought to determine HIV testing rates among recently separated Veterans in VHA care diagnosed with an STI. We hypothesized that, among Veterans with an STI diagnosis, HIV testing would be associated with demographic, military service-related, and clinical characteristics, and that higher rates would be found in patients with additional HIV risk factors, including substance abuse diagnosis, race, and younger age.
METHODS

Study Population
The study population comprised Veterans on the OEF/ OIF/OND roster provided by the Defense Manpower Data Center-Contingency Tracking System Deployment File to the Women Veterans Cohort Study. 17 The roster contained information on 756,576 personnel who separated from the US military between September 11, 2001 and September 30, 2013, and who enrolled for VHA services. We limited the sample to 244,195 Veterans who had at least 1 VHA primary care encounter (stop codes 310, 322, 323) between January 1, 2004 and December 31, 2010 that occurred within 1 year after their military separation date. We applied these criteria because STI diagnoses typically occur in primary care, to allow for 1 year of observation to diagnose an STI, and an additional year after the STI diagnosis to allow time for HIV testing. We excluded Veterans diagnosed with HIV >7 days before an STI diagnosis (n = 6), and those who died within the first year of observation (n = 346). The analytic sample included 243,843 Veterans. The study was approved by the Research and Development Committee at VA Connecticut Healthcare System (West Haven, CT) and the Human Investigation Committee at the Yale School of Medicine (New Haven, CT).
Data Sources
The roster includes data on sex, date of birth, race, last military rank (eg, officer), branch (eg, Army), and deployment dates. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) codes for STI and comorbid conditions were ascertained from the VHA Corporate Data Warehouse. We searched for ICD-9 codes used by the Armed Forces Surveillance Center report on STIs: chlamydia, gonorrhea, herpes simplex virus (HSV), and syphilis diagnostic codes, except for human papillomavirus (HPV), as many of these are nonvenereal infections (Table 1) . 9 ICD-9 comorbidity codes were mapped into validated groupings, such as major depressive disorder (MDD). 18 A Veteran was considered to have a comorbid condition if codes occurred on Z2 outpatient or Z1 inpatient visit(s). 19, 20 We examined high-prevalence chronic conditions that were likely active at the time of the STI diagnosis, and that may be associated with risk for HIV. We then searched laboratory data for evidence of HIV testing and test results within 1 year after the STI among those with an STI. We counted tests conducted up to 7 days before the STI diagnosis to account for reporting delays.
We validated the use of ICD-9 codes to identify STI diagnoses in our cohort. Two clinicians (J.A.W. and C.A.B.) reviewed the clinical progress notes of 100 randomly selected patients (50 with an STI diagnosis and 50 without). J.A.W. is a nurse midwife and advanced practice nurse, and C.A.B. is a medical doctor. Among those with a diagnosis, the reviewers verified that the participant had the STI identified by ICD-9 code. Among those without an STI code, reviewers verified that no STI diagnosis occurred within the observation period. Agreement between an ICD code-based STI diagnosis and clinician review was k = 0.80 [95% confidence intervals (CIs), 0.69-0.92]. 21 
Analysis
We used Poisson regression with a log link and robust variance estimates to calculate relative risks (RR) and 95% CI. All variables were entered into the model as covariates. Analyses were performed using SAS 9.2.
RESULTS
The mean age of the sample (N = 243,843) was 31 years (range, 18-69 y), 60% were white, and 88% were male. A majority had served in the Army (76%), and 46% had multiple deployments. Nearly 6% were diagnosed with MDD, 7% with alcohol use disorder, 2% with drug use disorder, and 22% with PTSD. The median length of time between military separation and first VHA primary care encounter was 145 days.
In this sample, 1815 (0.74%) Veterans had Z1 STI diagnoses. Older Veterans were less likely to be diagnosed with an STI (RR = 0.97 per year of age; 95% CI, 0.96-0.97), whereas women (RR = 2.94; 95% CI, 2.64-3.26), blacks (RR = 2.02; 95% CI, 1.79-2.29), and Hispanics (RR = 1.22; 95% CI, 1.05-1.42) were more likely. Air Force (RR = 1.34; 95% CI, 1.11-1.62), Marine Corps (RR = 1.16; 95% CI, 1.00-1.35), and Navy (RR = 1.57; 95% CI, 1.35-1.83) Veterans were significantly more likely to have a diagnosis compared with those who served in the Army, as were those with multiple deployments (RR = 1.15; 95% CI, 1.04-1.26). A diagnosis of MDD (RR = 1.19; 95% CI, 1.00-1.42), alcohol disorder (RR = 1.29; 95% CI, 1.08-1.53), drug use disorder (RR = 1.60; 95% CI, 1.24-2.07), and PTSD (RR = 1.30; 95% CI, 1.16-1.46) were associated with significantly higher rates of diagnoses ( Veterans with an STI diagnosis were significantly more likely to have had an HIV test than those without (34.9% vs. 7.3%, P < 0.0001). Among Veterans with an STI diagnosis, older age was associated with a lower rate of HIV testing (RR = 0.97; 95% CI, 0.96-0.98), whereas black race (RR = 1.33; 95% CI, 1.14-1.55), Hispanic ethnicity (RR = 1.44; 95% CI, 1.21-1.72), Marine Corps service (RR = 1.18; 95% CI, 1.02-1.37), multiple deployments (RR = 1.14; 95% CI, 1.00-1.29), alcohol (RR = 1.21; 95% CI, 1.01-1.46), drug use (RR = 1.42; 95% CI, 1.12-1.79), and PTSD (RR = 1.15; 95% CI, 1.00-1.32) were associated with higher rates of HIV testing.
Although Veterans with an STI diagnosis had higher HIV testing rates than those without (34.9% vs. 7.3%, P < 0.0001), they were not more likely to have a positive test result (1.1% vs. 1.4%, P = 0.53). 
DISCUSSION
Our study demonstrates that recent Veterans with an STI diagnosis were significantly more likely to have had an HIV test than those without. However, less than half of these Veterans were tested for HIV. Even more concerning is the fact that HIV testing among those with an STI diagnosis varied by Veteran characteristics, some of which are associated with higher risk for HIV, such as substance use disorders. This suggests that having an STI alone was not sufficient to prompt HIV testing.
These results are best understood in the context of VHA policy on HIV testing. Before 2009, VHA focused on risk-based testing and written informed consent, in addition to pretest and posttest counseling. In August of 2009, VHA updated its HIV testing policy to include testing all adults of any age at least once, and its informed consent policy to eliminate the need for pretest and posttest counseling and require only verbal consent. 22, 23 In conjunction with these policy changes, VHA developed and implemented an electronic reminder to both prompt and facilitate HIV testing. 24 Finally, VHA has had numerous successes expanding HIV testing beyond the primary care provider to include other points of contact such as emergency department care, 25 nurse initiated rapid testing, 26 and mental health. 27 Our study covers the 5 years before and the 2 years after this change. Therefore, the very high rates of HIV seropositivity seen in our study likely reflect risk based rather than universal testing.
In addition to universal testing, the VHA Directive 2009-036 specifically states that "(a)ll patients who are documented to be HIV negative and who have risk factors or clinical indications of HIV must be tested for HIV at least annually, provided they consent." 23 Risk factors listed include: injection drug use, being a sexual partner of an injection drug user, exchanging sex for money or drugs, being a sexual partner of someone who is infected with HIV, men who have sex with men, and heterosexuals who have had or whose sexual partners have had >1 sexual partner since their most recent HIV test. 23 It is possible that because an STI diagnosis was not included on this list that an STI diagnosis was not sufficient to trigger HIV testing. It is also possible that an HIV test was offered, but the patient refused. Rewording the Directive and providing patient education about the importance of HIV testing may encourage more appropriate HIV testing.
Our study has a number of limitations. Unlike the armed services, VHA does not have an active STI surveillance program, and we are not able to assess the true rate of STIs in the Veteran population. Thus our results highlight rates of STI diagnoses and not rates of STIs. Furthermore, as the analysis was based on ICD-9 codes, there is a risk for misclassification. However, our validation of an STI diagnosis by chart review demonstrated a high level of agreement between expert assessment of the patient record and ICD-9 code. We were also unable to differentiate between incident and prevalent STI diagnoses for persons identified with chronic STI conditions such as HSV. Finally, cohort members were only assessed for 1 or 2 years, depending on their STI status. It is likely that a subset of patients with an STI diagnosis may have had another, or multiple other, STI diagnoses over the follow-up period. Nevertheless, the occurrence of a single STI clearly demonstrates risk for HIV and a need for testing. The variations in STI diagnosis rates by prior military service characteristics may reflect differences in availability and/or attention to comprehensive examinations during deployment. Strengths of the study include a large and diverse national sample, and the use of standardized EHR data using ICD-9-CM codes which were validated by chart reviews conducted by clinical experts. OEF/OIF/OND Veterans are more likely to enroll for VHA care than prior military cohorts, and the national integrated health care system and EHR allow for a fuller assessment than may be possible from more fractured care settings. In addition, most data on STIs and HIV in military personnel come from studies of new recruits or those on active duty, and not among recent Veterans. 28 Risk behaviors for STI and HIV may persist among recent Veterans returning to their communities; however, routine surveillance is no longer performed.
Our work demonstrates that rates of HIV testing among recent Veterans with an STI diagnosis are suboptimal, highlighting the need for further research to explore barriers to testing. Rates of HIV testing in general, however, had increased over the course of the study, particularly after 2009, suggesting that the VHA policy on universal testing may lead to better identification of and earlier entry into care for Veterans infected with HIV.
